Strong earnings boosted the markets during the midday with the Dow soaring 105 points to 17,594. Nasdaq leaped 97 points to 5,017.
On the upside
Netgear (Nasdaq: NTGR) reported third quarter earnings that surpassed analyst expectations by a wide margin.
Horizon Pharma (Nasdaq: HZNP) issued a statement denying allegations that it owned specialty pharmacies that sold its products and clarifying that the average prices of DUEXIS, VIMOVO, PENNSAID and RAYOS have not increased over the past year.
athenahealth (Nasdaq: ATHN) reversed year ago losses to post a greater than expected profit for the third quarter as revenue climbed.
On the downside
Ocular Therapeutix (Nasdaq: OCUL) reported that OTX-TP reduced intraocular pressure in a Phase 2b clinical trial but the study did not detect statistically significant differences between patient groups.
Westmoreland Coal (Nasdaq: WLB) reported a loss for the third quarter and lowered its full year forecast.
Stericycle (Nasdaq: SRCL) disappointed with sharply lower third quarter earnings that fell short of expectations.
In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 4 on the NYSE and by more than 3 to 2 on Nasdaq. The broader S&P 500 gained 16 points to 2,069. Bitcoin added $2 to $274.
